Tokyo Research Laboratories, Kyowa Hakko Kogyo, Co. Ltd., 3-6-6 Asahi-machi, 194-8533, Tokyo, Japan,
Cytotechnology. 2001 Nov;37(3):133-41. doi: 10.1023/A:1020585320775.
The hybridoma cell line KM50 originally produces a monoclonal antibody at a concentration of approximately 40 mg ml(-1) in ascites. To investigate the possibility to apply this expression system to the production of useful proteins, the cDNA encoding human granulocyte colony-stimulating factor was inserted by homologous recombination into just downstream of the promoter of the active immunoglobulin heavy chain gene of KM50. Site directed integration of targeting DNAs resulted in the disruption of expression of the immunoglobulin heavy chain proteins with a frequency of 1 in 10 approximately 100 G418-resistance transfectants. One of the monoclonal antibody-deficient transfectants produced25 ng ml(-1) of granulocyte colony-stimulating factor in the supernatant of its cell culture the number of molecules of which corresponds to that of the monoclonal antibody originally produced by KM50. However, when this transfectant was injected intraperitoneally, it produced only a 9 mug ml(-1) concentration of granulocyte colony-stimulating factor in ascites, which is approximately 3 orders of magnitude less than the monoclonal antibody. This method may be applicable to production of other recombinant proteins, although further optimization in the conditions of production would be needed in order to reach much higher yields.
杂交瘤细胞系 KM50 最初在腹水培养液中的浓度约为 40 毫克/毫升,可产生单克隆抗体。为了研究该表达系统在生产有用蛋白中的应用,我们通过同源重组将编码人粒细胞集落刺激因子的 cDNA 插入 KM50 的免疫球蛋白重链基因启动子下游。靶向 DNA 的定点整合导致免疫球蛋白重链蛋白的表达被破坏,其频率约为每 10 个~100 个 G418 抗性转染体中有 1 个。在其细胞培养上清液中,一个单克隆抗体缺陷型转染体产生 25 纳克/毫升的粒细胞集落刺激因子,其分子数与 KM50 最初产生的单克隆抗体相当。然而,当将该转染体腹膜内注射时,在腹水中仅产生 9 微克/毫升的粒细胞集落刺激因子浓度,这大约是单克隆抗体的 3 个数量级。该方法可能适用于生产其他重组蛋白,尽管需要进一步优化生产条件以达到更高的产量。